Ross Harris

7.8k total citations · 2 hit papers
68 papers, 3.9k citations indexed

About

Ross Harris is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Ross Harris has authored 68 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Epidemiology, 34 papers in Infectious Diseases and 16 papers in Hepatology. Recurrent topics in Ross Harris's work include Hepatitis C virus research (15 papers), Tuberculosis Research and Epidemiology (13 papers) and HIV, Drug Use, Sexual Risk (13 papers). Ross Harris is often cited by papers focused on Hepatitis C virus research (15 papers), Tuberculosis Research and Epidemiology (13 papers) and HIV, Drug Use, Sexual Risk (13 papers). Ross Harris collaborates with scholars based in United Kingdom, Denmark and United States. Ross Harris's co-authors include Jonathan A C Sterne, George Davey Smith, Roger Harbord, Shah Ebrahim, Debbie A. Lawlor, Naveed Sattar, Abigail Fraser, Daniela De Angelis, Ibrahim Abubakar and Rebecca Beynon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Ross Harris

62 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials

2012 768 citations Jelena Savović, Hayley E Jones et al. profile →
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study

2021 372 citations Ross Harris, Daniela De Angelis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ross Harris United Kingdom	25	1.5k	1.4k	503	484	341	68	3.9k
Su Jin Jeong South Korea	31	1.4k 0.9×	1.4k 1.0×	635 1.3×	169 0.3×	183 0.5×	258	4.2k
Rodolphe Thiébaut France	42	1.7k 1.1×	3.3k 2.4×	628 1.2×	422 0.9×	428 1.3×	178	7.5k
Janet Raboud Canada	45	2.7k 1.8×	3.2k 2.3×	708 1.4×	255 0.5×	116 0.3×	238	7.1k
Félix Gutiérrez Spain	42	2.2k 1.4×	3.7k 2.7×	496 1.0×	349 0.7×	159 0.5×	281	6.5k
Thomas Hanslik France	31	1.6k 1.1×	813 0.6×	321 0.6×	205 0.4×	65 0.2×	197	4.4k
Susan P. Fisher‐Hoch United States	40	1.9k 1.3×	2.9k 2.1×	246 0.5×	388 0.8×	526 1.5×	165	5.9k
Fritz François United States	29	1.0k 0.7×	2.4k 1.7×	1.9k 3.7×	381 0.8×	164 0.5×	63	6.5k
Sara L. Thomas United Kingdom	40	3.3k 2.2×	834 0.6×	784 1.6×	177 0.4×	449 1.3×	78	6.9k
Matthew F. Daley United States	42	3.1k 2.1×	1.8k 1.3×	834 1.7×	218 0.5×	213 0.6×	237	7.2k
Grace Lui Hong Kong	42	3.5k 2.3×	2.6k 1.9×	344 0.7×	1.0k 2.1×	139 0.4×	171	6.1k

Countries citing papers authored by Ross Harris

Since Specialization

Citations

This map shows the geographic impact of Ross Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Harris more than expected).

Fields of papers citing papers by Ross Harris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Harris. The network helps show where Ross Harris may publish in the future.

Co-authorship network of co-authors of Ross Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Ross Harris. A scholar is included among the top collaborators of Ross Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross Harris. Ross Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hibbert, Matthew, Ross Harris, Caroline Sabin, et al.. (2025). Understanding hepatitis C virus reinfections in England in the context of eliminating viral hepatitis as a public health concern. International Journal of Drug Policy. 145. 105005–105005.

Mitchell, Holly, et al.. (2025). Heterogeneity in Risk and Implications for Hepatitis C Reinfection in People Who Inject Drugs in England. Journal of Viral Hepatitis. 32(2). e14052–e14052. 1 indexed citations

Simmons, Ruth, Ross Harris, Aaron G. Lim, et al.. (2024). Estimating Prevalence and Number of People With Chronic Hepatitis B: A Multiplier Method Based on Public Health Surveillance Data in UK (2015–2021). Journal of Viral Hepatitis. 32(4). e14019–e14019.

Fifer, Helen, Ashley Otter, Rachel Pitt, et al.. (2023). P031 Prevalence of Mpox-specific antibodies in sera collected between January – September 2022 in England. A cross-sectional seroprevalence study. A38.1–A38.

Croxford, Sara, Vivian Hope, Monica Desai, et al.. (2022). Epidemiology of HIV infection and associated behaviours among people who inject drugs in England, Wales, and Northern Ireland: Nearly 40 years on. HIV Medicine. 23(9). 978–989. 5 indexed citations

Bardsley, Megan, Ellen Heinsbroek, Ross Harris, et al.. (2021). The impact of direct‐acting antivirals on hepatitis C viraemia among people who inject drugs in England; real‐world data 2011–2018. Journal of Viral Hepatitis. 28(10). 1452–1463. 11 indexed citations

Plumb, Ian D., Ross Harris, Helen K. Green, et al.. (2021). Changes in characteristics and case‐severity in patients hospitalised with influenza A (H1N1) pdm09 infection between two epidemic waves—England, 2009–2010. Influenza and Other Respiratory Viruses. 15(5). 599–607. 1 indexed citations

Presanis, Anne M., Ross Harris, Peter Kirwan, et al.. (2021). Trends in undiagnosed HIV prevalence in England and implications for eliminating HIV transmission by 2030: an evidence synthesis model. The Lancet Public Health. 6(10). e739–e751. 9 indexed citations

Harris, Ross, Heather Whitaker, Nick Andrews, et al.. (2021). Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers. Journal of Infection. 82(5). 162–169. 28 indexed citations

10.

Jones, Hayley E, Ross Harris, Matthias Pierce, et al.. (2020). Estimating the prevalence of problem drug use from drug‐related mortality data. Addiction. 115(12). 2393–2404. 23 indexed citations

11.

Harris, Ross, H Harris, Sema Mandal, et al.. (2019). Monitoring the hepatitis C epidemic in England and evaluating intervention scale‐up using routinely collected data. Journal of Viral Hepatitis. 26(5). 541–551. 31 indexed citations

12.

Harris, Ross, Maeve K. Lalor, Morris C Muzyamba, et al.. (2019). Effectiveness of pre-entry active tuberculosis and post-entry latent tuberculosis screening in new entrants to the UK: a retrospective, population-based cohort study. The Lancet Infectious Diseases. 19(11). 1191–1201. 15 indexed citations

13.

Thomas, H Lucy, Ross Harris, Morris C Muzyamba, et al.. (2018). Reduction in tuberculosis incidence in the UK from 2011 to 2015: a population-based study. Thorax. 73(8). 769–775. 7 indexed citations

14.

Zhao, Hongxin, Ross Harris, John Ellis, Matthew Donati, & Richard Pebody. (2017). Epidemiology of parainfluenza infection in England and Wales, 1998–2013: any evidence of change?. Epidemiology and Infection. 145(6). 1210–1220. 16 indexed citations

15.

Fatima, Razia, D. A. Enarson, Sven Gudmund Hinderaker, et al.. (2014). Investigation of presumptive tuberculosis cases by private health providers: lessons learnt from a survey in Pakistan. Public Health Action. 4(2). 110–112. 7 indexed citations

16.

Harris, Ross, Brenda Thomas, Ruth Chapman, et al.. (2014). Increased uptake and new therapies are needed to avert rising hepatitis C-related end stage liver disease in England: Modelling the predicted impact of treatment under different scenarios. Journal of Hepatology. 61(3). 530–537. 65 indexed citations

17.

Fatima, Razia, et al.. (2013). Estimating tuberculosis burden and case detection in Pakistan. The International Journal of Tuberculosis and Lung Disease. 18(1). 55–60. 32 indexed citations

18.

Harris, Ross, et al.. (2011). Spatial mapping of hepatitis C prevalence in recent injecting drug users in contact with services. Epidemiology and Infection. 140(6). 1054–1063. 6 indexed citations

19.

Gilbert, Rebecca, Richard M. Martin, Rebecca Beynon, et al.. (2011). Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose–response meta-analysis. Cancer Causes & Control. 22(3). 319–340. 118 indexed citations

20.

Harris, Ross, et al.. (2000). METABIAS: Stata module to test for small-study effects in meta-analysis. RePEc: Research Papers in Economics. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact